The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2009

Volume 5 Supplement F

Part III – Ploughing new ground, update of the bioabsorbable programmes

Engineering a bioresorbable stent: REVA programme update
Pollman M
December 30, 2009
Novel fully bioabsorbable salicylate-based sirolimuseluting stent
Jabara R, Pendyala L, Geva S, Chen J, Chronos N, Robinson K
December 30, 2009
OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings
Cottone R, Thatcher L, Parker S, Hanks L, Kujawa D, Rowland S, Costa M, Schwartz R, Onuma Y
December 30, 2009
Challenges related to development of bioabsorbable vascular stents
Berglund J, Guo Y, Wilcox J
December 30, 2009
Elixir Medical’s bioresorbable drug eluting stent (BDES) programme: an overview
Yan J, Bhat V
December 30, 2009
A.R.T.: concept of a bioresorbable stent without drug elution
Lafont A, Durand E
December 30, 2009
NEVO™: a new generation of sirolimus-eluting coronary stent
Falotico R, Parker T, Grishaber R, Price S, Cohen S, Rogers C
December 30, 2009
Current state of the absorbable metallic (magnesium) stent
Waksman R
December 30, 2009
Everolimus-eluting bioabsorbable stent – Abbot Vascular programme
Onuma Y, Piazza N, Ormiston J, Serruys P
December 30, 2009
Assimilating the current clinical data of fully bioabsorbable stents
Di Mario C, Borgia F
December 30, 2009
Ten-year follow-up of the IGAKI-TAMAI stent.
Onuma Y, Garg S, Okamura T, Ligthart J, van Geuns R, de Feyter P, Serruys P, Tamai H
December 30, 2009
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke